The prognostic significance of high TGFβ1 level on DFS observed in node-negative breast cancer patients suggest that the determination of tumoral TGFβ1 status might help to identify a high-risk population early in tumour progression, for which a more appropriate therapy should be established. Here, TGFB1 is linked to neoplasm.